Shots:

• Roche has launched Elecsys Anti-SARS-CoV-2 S Ab for markets accepting the CE Mark. The company has filed for US FDA’s EUA
• The test can quantitatively measure the level of Abs against SARS-CoV-2 in patients who have been exposed to the virus and can aid in characterizing a vaccine-induced immune response
• Using the Elecsys Anti-SARS-COV-2 S Ab test together with the Elecsys Anti-SARS-CoV-2 test-launched in May'2020- can aid effectively in determining the percentage of a population who already have Abs against SARS-COV-2

­ Ref: Roche | Image: Roche